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     Background: A pharmacy information system must retrieve process and update the information it 
obtains for safe and effective use of drugs. It is used to manage drug usage in the patient health care 
process and to communicate a large volume of information to pharmacy and pharmaceutical firms. 
Bearing in mind such issues, the current study adopted a descriptive method of research to investigate 
the pharmacy information systems in university hospitals and their relationship with pharmaceutical 
firms. The research data were collected through observation and interview based on a checklist and a 
questionnaire. Validity and reliability of the data gathering tools were specified through content 
validity and test re-test methods. The collected data were then analyzed, using a set of descriptive 
statistics. According to the results, pharmacy information systems in the hospitals under study were 
partially computerized. Databases for drugs, patients and prescriber databases, with different values 
of 50.1%, 21.9%, and 33.3% respectively, were not complete, as had been recorded in the pharmacy 
information system of the hospitals. The pharmacy information system is normally used to support 
therapeutic activities and the inventory, but such support had not been provided for 43.9 % of the 
hospitals. 32.2 % of the hospitals under study had not reported pharmaceutical information such as 
statistical data and drugs’ prices. Also, 27.3% of the pharmaceutical firms did not have any 
relationship with pharmacy information systems. Pharmaceutical companies had developed some 
relationship, on marketing issues, with hospital pharmacies. The findings were in favor of further 
therapeutic activities by pharmacy information systems, which could be achieved by improving 
relationship between hospitals and pharmaceutical firms, particularly in Tehran. This could help to 
manage drug consumption and supervision, after marketing, in order to eliminate adverse drug 
reactions and develop high quality pharmaceutical services.   
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INTRODUCTION  
      Hospital pharmacy supervision is to ensure 
that medicines are accessed and used safely by 
patients and professionals both within the 
environments of a hospital and beyond (1,2,3). 
Pharmacy involves information processing, 
which means retrieving information from one 
file and using it to compare, update, or display 
information from another file (4). The 
pharmacist could play an essential role in 
providing accurate data for managing patient 
care. Information systems are now necessary 
to help pharmacists to perform their expanding 
list of daily tasks efficiently (5). The 
pharmacy information system collects, stores 
and manages information related to drugs and 
supervises the use of drugs in line with patient 
care (6). The pharmacy information system 
can rely on management information system 
to track and dispense drugs to hospitals and 
health care organizations (7). Pharmacy 
information systems are also among the most 
widely used clinical information systems 
today (8). 
Pharmacy information systems have regularly 
been used in the delivery of pharmacy services 
since the early 1980s. Today’s systems 
perform many clinical decision support 
functions such as dose range checking, drug-
drug interaction checking, food-drug 
interaction checking and drug-laboratory 
results checking (9). Pharmacy information 
systems could reduce the risks involved in 
drug dispensation and drug interpretation 
errors (10, 11, 12). 
     The chief medical officer, medical staff  
committee and pharmacy directors can use 
retrospective data, generated by the pharmacy
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information system, to identify trends in drug 
use, and to support formulary or inventory 
management decisions. The information could 
also be used to achieve compliance with the 
relevant guidelines or protocols. Medications 
use evaluation, adverse drug reaction (ADR) 
review, and other clinical and regulatory 
requirements through the primacy information 
system (13). In addition, pharmaceutical firms 
and pharmacies are communicating everyday 
to transmit a large amount of information (14). 
Comprehensive and updated information 
transmission of the pharmacies and drug 
companies have significant role in drug use 
management. Pharmaceutical companies are 
commercial and scientific entities, which 
produce the necessary commercial and 
scientific information (15). Pharmaceutical 
industry spends much more time and a lot 
more resources on generation, collaboration, 
and dissemination of medical information than 
it does on production of medicines. This 
information is essential as a resource for 
development of medicines (16). 
Pharmaceutical firms collect information 
about the market, customers and products of 
the company, evaluate and analyze them, and 
then they deliver the information to the 
production, research and development units in 
order to improve their quality (17). Pharmacy 
information system is capable of delivering a 
list of drugs that need to be ordered. The 
computer using the program adopted for this 
purpose often provides reports on drug 
purchase histories that are invaluable for the 
hospital inventory control management. Such 
reports play an important role in fulfilling 
information needs of pharmaceutical 
industries (4). In line with such issues, the 
current research is intended to investigate the 
status of pharmacy information systems in 
university hospitals, on the one hand, and their 
relationship with pharmaceutical firms, on the 
other.  
 
MATERIALS AND METHODS 
     This study is a descriptive and cross 
sectional research which investigates the 
informatics status of 13 university hospital 
pharmacies and their relationship with 22 
pharmaceutical firms. The study used a 
random sampling formation system to choose 
and investigate 10 drug manufacturing firms 
and 7 drug distributing firms. The data were 
collected through observation and interview 
based on a checklist and a questionnaire. The 
validity of data gathering tools was specified 
based on content validity measures; also the 
reliability of research tools was identified by 
test re-test method, which showed a reliability 
coefficient of r=0.85%. The collected data 
were then analyzed using a set of descriptive 
statistics.    
 
RESULTS 
     According to the results, the pharmacy 
information systems in the hospitals under 
study were partially computerized. Regarding 
the incoming input, the data elements of drug, 
patient, and prescriber databases, with 
different values of 50.1%; 21.9% and 33.3%, 
did not indicate any satisfactory records. This 
means that the incoming data had not been 
sufficiently entered into the pharmacy 
information system of the hospitals under 
study (Tables 1, 2, 3).  
Important data elements such as storage drug 
requirements, drug strength, time intervals and 
start-end date of drug consumption, formulary 
list, national and local instructions of the drug, 
and patient education information had not 
been entered into pharmacies databases. 
Patients’ clinical information including 
pregnancy data, body immunity, function of 
kidney, cardiac, and nutrition qualification did 
not exist in the pharmacy information systems. 
Patient complaints, disease symptoms and 
disease processes, including present problem 
of the patient, prognosis of the disease (like 
the disease severity, patient inability and 
impairment) had not been entered into the 
hospital pharmacy information systems. 
Patient demographic information, 
qualifications of drug consumption, and other 
relevant data were not accurate while 45.1%, 
25.7%, and 38.5% of the faulty data had been 
entered into the system.  
     In addition to the support provided for 
therapeutic activities, and preparations made 
for patient’s administration records, online 
registration of drug orders and prescriptions 
are also very important functions, performed 
by pharmacy information systems, but none of 
these functions existed in the hospitals under 
study.  
     Most of the essential data items, such as the 
drugs consumed by patients (based on drug 
class and diagnosis) and drug consumption 
indicators (based on WHO), were not 
performed in the hospitals (Table 5).   
The pharmacy information system did not 
issue any report concerning drug interactions 
although such reports could play a significant 
role in preventing interactions (Table 6).  
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Standards and instructions of the hospitals 
under study did not regard information 
exchange confidentiality and other 
internationally recognized standards of the 
American Society of Pharmacists in their 
databases. Only 43.7%, 23%, and 64.4% of 
the hospitals had the necessary hardware and 
software for collecting, processing and 
distributing information, including 
prescription information, computer network 
and barcode equipment.      
     Pharmacists, physicians, nurses, hospital 
managers, dentists and the administrative staff 
were major users of the drugstore informatics 
system. Pharmaceutical firms mostly used the 
hospital pharmacy information system.  
     Pharmaceutical firms received the greatest 
degree of   information on drug marketing 
from hospital pharmacies but even this did not 
go beyond 31.8% of the marketing 
information. Merely one of the pharmaceutical 
firms received sufficient information to 
supervise the products’ quality after they had 
been sold (Table 7). Only 27.3% of the 
hospital pharmacies received sale and 
purchase information of the drugs. The 
pharmaceutical firms did not receive any 
information on the quality of the drugs already 
used or those newly produced.  
     Only one of the pharmaceutical firms sent 
some information about adverse drug reactions 
to the hospital pharmacies. The firms did not 
send any information about their research on 
the development of the drugs to the hospital 
pharmacies.   
   Most of the hospital pharmacies, i.e. 68.2%, 
were critical of the low quality of the drugs 
produced by pharmaceutical firms. 
Nonetheless, they did not send any research-
based information to the pharmaceutical firms 
to verify their claims. (Table 8) 
 
               Table 1. Data elements of drug database at the      










       


































































Frequency (percent) Data elements 
12 (92.3) Generic name 
3 (23) Brand name 
12 (92.3) Drug type 
12 (92.3) Drug dose 
0 Storage requirements 
0 Drug strength 
12 (92.3) Dose interval schedule 
10 (79.9) Expiration date 
0 Start  date of administration 
0 Stop date of administration 
1 (7.6) Therapeutic code 
0 Hospital formulary 
1 (7.6) Pharmacologic-therapeutic category 
9 (69.2) Drug identification number 
10 (79.9) Adverse drug reactions 
3 (23) Drug interactions 
0 Drug guidelines (national/local) 
0 Patient education information 
7 (53.8) Drug reference 
13 (100) Dispensing date of pharmacy 
13 (100) Quantity of drugs dispensed by pharmacy 
13 (100) Minimum inventory 
2 (15.3) Pharmacist verification code 
12 (92.3) Purchase contract information 
11 (84.6) Primary vendor 
11 (84.6) Secondary vendor 
1 (7.6) Manufacture name 
8 (61.5) Reorder quantity  
12 (92.3) Acquisition cost 
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Table 2. Data elements of patient database at the 




13 (100) Demographic information 
0 Complications, symptoms 
 and processes 
0 Clinical information 
13 (100) Drug usage status 
13 (100) Other information 
 
 
     Table 3. Data elements of prescriber database at the      




13 (100) Prescriber name 
13 (100) License number 
0 Identification number 
0 Signature 




Table 4. Functions of the pharmacy information system at the hospitals under study 
 
Frequency (percent) Functions 
0 Supporting clinical activities  
6 (46.1) Providing Patient medication profile 
13 (100) Reporting  
12 (92.3) Considering inventory management 
0 Preparing the administration of medication records 
3 (23) Profiling prescriber records 
13 (100) Providing online order entry 
13 (100) Presenting drug purchasing support 
13 (100) Presenting drug dispensing support 
13 (100) Preparing medication billing 
 





Processing Frequency (percent) 
Drug dose 4 (30.7) 
Drug cost by the patient 13 (100) 
Dispensing quantity of the pharmacy 13 (100) 
Minimum and maximum reordering by the pharmacy 7 (53.8) 
Hospital census (number of admissions, discharges and patients per day)  8 (61.5) 
Total drug use 12 (92.3) 
Drug usage by category 0 
Drug usage by diagnosis 0 
Drug usage by hospital service unit 12 (92.3) 
Volume of injectable drugs 2 (15.3) 
Total parental nutrition (TPN) 0 
Medicines Prepared  by the pharmacy (injectable fluids, ointments and mixtures)  4 (30.7) 
Workload of the pharmacy 9 (69.2) 














































Average of injectable items 0  
Percentage of injectable drugs with generic names 0  
 




The percentage of   prescriptions with a  minimum of one 
injectable drug 
0  
The percentage of prescriptions  based on the formulary list  0  
   Journal of Paramedical Sciences (JPS)                Winter 2011 Vol.2, No.1 ISSN 2008-4978 






Table 6. Reports of the pharmacy information system at the hospitals under study 
Frequency (percent) Report 
12 (92.3) Total number and value of items dispensed for outpatients and inpatients  
12 (92.3) Total number and value of items dispensed for inpatients 
12 (92.3) Total volume of drugs dispended from the pharmacy   
12 (92.3) Number of outpatient prescriptions 
1 (7.6) Emergency needs of wards for drug 
2 (15.3) Drug manufactures 
1 (7.6) Drug use review 
8 (61.5) Management report 
9 (69.2) Drug report 
11 (84.6) Statistical report 
12 (92.3) Inventory report 
0 Summary report of interaction type 
12 (92.3) Drug listing for purchasing  
12 (92.3) Drug listing by product type 
13 (100) Annual report 
8 (61.5) Expired list of drugs with user defined period 
12 (92.3) Drug pricing 
12 (92.3) Drug cost, determined by the third party payer  




Table7. Information transmitted to pharmacy information 





6 (27.3) Selling 
7 (31.8) Marketing  
0 Adverse drug reaction  
0 Research and development 
1 (4.5) Post marketing surveillance 




Table8. Information Transmitted to drug companies by 






6 (27.3) Selling  
7 (31.8) Marketing  
9 (40.9) Adverse drug reaction  
0 Research and development 




     The Pharmacy information system is vital 
in both inpatient and outpatient pharmacy 
service areas (13). Most pharmacy information 
systems both simplify and streamline 
medication dispensing and inventory control 
by automatically checking all drug orders and 
dosages against the patient profiles to ensure 
the intake of proper dosage, and to prevent 
contradictions. Such systems generally 
increase the efficiency of drugs’ distribution 
and improve the monitoring of their proper 
usage (8). The information contained in 
pharmacy information systems is important to 
the management of the pharmacy (14). It 
enables pharmacists to maintain a database of 
patients, prescribers, and the drugs. The 
database (information) can also be used to 
reduce errors and to speed up the handling of 
subsequent prescriptions and refills (5). 
     According to Bates’ assertions (18), it is 
essential to consult with specialists like 
pharmacists and medical informatics if we are 
to design our databases appropriately. 
Appropriate databases can reduce medication 
errors significantly (18). It can also help to 
reduce pharmaceutical errors significantly and 
to manage the inventory of hospital 
pharmacies effectively. Brown maintains that 
pharmacy information system must support 
checking functions such as dose range, drug-
drug interaction, food-drug interaction, and 
drug-laboratory results. Studies have shown 
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that between 6.5% and 23% of adverse drug 
reactions are attributable to drug interaction 
and PIS is capable of controlling drug 
interactions (9). Regarding the study results, 
pharmacy information system must support 
pharmaceutical therapeutic processes. 
According to Reddy’s studies (2004), the 
precise calculation of medication dosages is 
the most critical element in providing 
pharmaceutical care and in achieving optimal 
patient outcome. Sometimes, even minor 
dosage calculation errors can be dangerous to 
the patient and may prove very costly (19). 
According to Kaushal’s study (2002), bar 
coding can decrease administration errors up 
to 80% (20), but only 30.7% 0f the hospitals 
understudy measure drug consumption dosage. 
Thus, it is necessary to prevent drug 
interactions and patient drug therapy issues 
through pharmaceutical data processing. 
According to a study carried out by Oraby 
(2008) on pharmacy information system 
reports, the system must prepare drug 
utilization review reports to analyze trends and 
costs of drug therapy (21). 
      In his resent study, Semple (2009) 
highlighted the role of reports on 
understanding and preventing medication 
errors (22). Nonetheless, the results of the 
study show that just one of the hospitals under 
study provides review report on drug use. 
American pharmacists’ health systems society 
demonstrates that pharmacy information 
system must provide integrated information 
based on standards related to availability of 
proper facilitates for health system 
components.  Computer software vendors and 
pharmaceutical suppliers are in charge of 
providing standards for definition, collection, 
coding, and exchange of clinical data used in 
the medication process (23). According to a 
study by Zoutman (2004), the Act calls for 
informed consent for disclosure of personal 
information (24). The Patients` confidentiality 
of information must be safeguarded, as an 
essential necessity in the pharmacy 
information system. None of the hospital 
pharmacies under study properly observe the 
international confidentiality standards, 
although the existing standards not only do not 
allow information abuse but also present 
special measures to facilitate the collection 
and distribution of information accurately. 
Moreover, despite the significance of proper 
communication between pharmaceutical firms 
and hospital pharmacies, 27.3% of the firms 
did not establish any communicative links 
with hospitals. 
     American society of pharmaceutical 
research and drug manufactures have 
demonstrated that pharmaceutical 
representatives can provide physicians and 
other health care professionals with necessary 
information about new studies on clinical data, 
new dosing information, and updates on safety 
and risk information. Due access to this 
information presented to care provider by 
pharmaceutical representatives would entail 
effective patient care (25). Moreover, many 
doctors cite pharmaceutical representatives as 
one of the main sources of information on the 
use of new drugs (26). 
     According to Zipkin (2005), 
pharmaceutical companies spend, on average, 
twice as much on marketing to physicians and 
the public as they do on research and 
development. The medical literature has 
demonstrated that promotional activities can 
influence the behavior of practicing 
physicians, such as prescription decisions and 
medication requests (27). Nonetheless, 
pharmaceutical firms submit less than 50% of 
drug marketing information to the hospital 
pharmacies. Thus pharmaceutical firms can 
play an important role in proper drug 
consumption by submitting precise and 
updated information to the relevant personnel. 
Pharmaceutical firms must particularly 
communicate with the relevant pharmacies to 
submit accurate information about the newly 
produced drugs to them. Although post 
marketing surveillance can play a significant 
role in improving health indicators and drug 
effectiveness, just one of the pharmaceutical 
firms collected data from the hospital 
pharmacies about the drugs that have been 
sold. Since complete assessment of a drug 
cannot, for practical reasons, be made before 
marketing, Post-marketing surveillance is 
essential in order to protect future patients 
against avoidable medication risks (28). Each 
manufacturer who wished to market a new 
drug was required to submit a request to the 
drug and food Administration, containing 
reports of investigations performed to show 
that the drug was safe for its intended use (29). 
The pharmaceutical firms under study did not 
receive any adverse drug reaction information 
from the pharmacies, although spontaneous 
reporting of suspected reactions is an 
important element of pharmacovigilance (30). 
pharmacovigilance is the science and activities 
relating to the detection, assessment, 
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understanding and prevention of adverse 
effects or any other drug-related problems 
(31). According to Carleton`s study (2005), 
the collection of relevant pharmacovigilance 
information and data is of special significance 
(32). The information system of a pharmacy is 
obliged to prepare the adverse drug reactions 
on the patient record independently of 
allergies (21). Moreover, pharmaceutical 
companies should provide accurate and 
complete warnings and contraindications for 
physicians and patients (33). The firms under 
study must deliver their reports to hospitals to 
reduce adverse reactions of the drugs and to 
safeguard Patients’ drug consumption. 
Hospital pharmacies must also report adverse 
drug reactions to pharmaceutical firms in 
order to assist them in improving the quality 
of pharmaceutical products and reducing 
adverse drug reactions. Although 
Pharmaceutical companies are the prime users 
of information throughout the 10 to 15 years 
of drug development processes (34), the firms 
under study did not receive any such 
information which could be used to enhance 
the quality of hospital pharmacies. Hospital 
pharmacy information system is a vital 
resource of data for research and development 
of the newly produced drugs. The information 
provided by the System is vital for the 
research dealing with the development of new 
drugs (5). So drug companies are expected to 
rely on these information resources to produce 
more effective drugs.  
      The pharmacy information system has a 
key role to play in delivering efficient 
pharmaceutical services. Its respective 
information can reduce drug consumption and 
drug production faults and improve drug 
therapy procedures. Data elements of drug 
therapy have important roles not only in 
reducing pharmaceutical errors and controlling 
drug interactions, but also in achieving 
business and economical purposes. Thus 
pharmacy information system designers are 
required to design these information databases 
more accurately by performing user 
information needs assessment studies. 
Moreover, as the current study implies, 
pharmaceutical firms and hospital pharmacies 
should be more actively involved in 
marketing, sales and purchase of drugs. 
However, the study indicated that many firms 
and pharmacies had very poor record of 
information exchange on important issue such 
as post marketing surveillance, research and 
development and adverse drug reactions. If 
pharmaceutical firms communicate more 
effectively with hospital pharmacies on such 
issues, they can certainly improve the quality 
of their pharmaceutical products, reduce drug 
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